Center for Research in Security Prices, LLC

đŸ‡ē🇸United States
Ownership
-
Employees
-
Market Cap
-
Website
Clinical Trials
Related News

Sildenafil and Pulmonary Artery Pressure

Phase 2
Terminated
Conditions
Pulmonary Hypertension
First Posted Date
2005-09-05
Last Posted Date
2013-10-08
Lead Sponsor
University of Chicago
Target Recruit Count
10
Registration Number
NCT00145938
Locations
đŸ‡ē🇸

University of Chicago, Chicago, Illinois, United States

A Research Study to See if a Change in Therapy for HIV Infection Can Improve the Immune Response to Treatment

First Posted Date
2005-09-05
Last Posted Date
2022-06-15
Lead Sponsor
University of Chicago
Target Recruit Count
20
Registration Number
NCT00145795
Locations
đŸ‡ē🇸

University of Illinois at Chicago, Chicago, Illinois, United States

Use of Atorvastatin (Lipitor) to Decrease Panel Reactive Antibody Titers

Phase 1
Completed
Conditions
End-Stage Kidney Disease
Interventions
Drug: Atorvastatin (Lipitor)
First Posted Date
2005-09-02
Last Posted Date
2013-01-10
Lead Sponsor
University of Chicago
Target Recruit Count
20
Registration Number
NCT00143741
Locations
đŸ‡ē🇸

The University of Chicago, Chicago, Illinois, United States

Genetics of Cardiovascular and Neuromuscular Disease

First Posted Date
2005-08-30
Last Posted Date
2024-07-26
Lead Sponsor
University of Chicago
Target Recruit Count
2000
Registration Number
NCT00138931
Locations
đŸ‡ē🇸

University of Chicago, Chicago, Illinois, United States

A Pilot Study Comparing the Efficacy of Group Versus Individual Anger Management in Subjects With IED

Phase 2
Completed
Conditions
Anger
Intermittent Explosive Disorder
First Posted Date
2005-08-05
Last Posted Date
2013-09-05
Lead Sponsor
University of Chicago
Target Recruit Count
72
Registration Number
NCT00127400
Locations
đŸ‡ē🇸

The University of Chicago, Chicago, Illinois, United States

A Study to Tailor Advance Directives

First Posted Date
2005-07-19
Last Posted Date
2013-09-05
Lead Sponsor
University of Chicago
Target Recruit Count
100
Registration Number
NCT00121004
Locations
đŸ‡ē🇸

The University of Chicago, Chicago, Illinois, United States

The Addition of Montelukast to Fluticasone in the Treatment of Perennial Allergic Rhinitis

First Posted Date
2005-07-12
Last Posted Date
2014-02-28
Lead Sponsor
University of Chicago
Target Recruit Count
102
Registration Number
NCT00119015
Locations
đŸ‡ē🇸

The University of Chicago, Chicago, Illinois, United States

Nasal Ocular Reflexes Contribute to Eye Symptoms

Not Applicable
Completed
Conditions
Rhinitis, Allergic, Seasonal
First Posted Date
2005-07-08
Last Posted Date
2013-09-05
Lead Sponsor
University of Chicago
Target Recruit Count
20
Registration Number
NCT00117832
Locations
đŸ‡ē🇸

University of Chicago, Chicago, Illinois, United States

Xolair in Patients With Chronic Sinusitis

Phase 4
Completed
Conditions
Sinusitis
Interventions
Drug: Anti-IgE antibody omalizumab or placebo
First Posted Date
2005-07-07
Last Posted Date
2013-09-30
Lead Sponsor
University of Chicago
Target Recruit Count
14
Registration Number
NCT00117611
Locations
đŸ‡ē🇸

The University of Chicago, Chicago, Illinois, United States

Docetaxel Based Chemotherapy Plus or Minus Induction Chemotherapy to Decrease Events in Head and Neck Cancer (DeCIDE)

First Posted Date
2005-07-07
Last Posted Date
2018-04-09
Lead Sponsor
University of Chicago
Target Recruit Count
285
Registration Number
NCT00117572
Locations
🇭🇷

University Hospital for Tumors Zagreb, Zagreb, Croatia

đŸ‡ē🇸

Joliet Oncology Hematology Associates, Joliet, Illinois, United States

đŸ‡ē🇸

University of Kansas Cancer Center, Kansas City, Kansas, United States

and more 23 locations
Š Copyright 2024. All Rights Reserved by MedPath
HomeTerms & ConditionsPrivacy Policy